Yulei Wang
City Of Hope National Medical Center
1 paper in the Anchorcite directory, published in 2020, cited 7,704 times in total.
ORCID profileResearch topics
Frequent co-authors
- Richard S. Finn · 1 paper
- Shukui Qin · 1 paper
- Masafumi Ikeda · 1 paper
- Peter R. Galle · 1 paper
- Michel Pierre Ducreux · 1 paper
- Tae‐You Kim · 1 paper
- Masatoshi Kudo · 1 paper
- Valeriy Vladimirovich Breder · 1 paper
Papers
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular CarcinomaNew England Journal of Medicine · 2020 · 7,704 citations
BACKGROUND: The combination of atezolizumab and bevacizumab showed encouraging antitumor activity and safety in a phase 1b trial involving patients with unresectable hepatocellular carcinoma. METHODS: In a global, open-label, phase 3 trial, patients with unresectable hepatocellular carcinoma who had not…
Metadata from OpenAlex (CC0).